Relentless Venture Fund is a Canadian venture capital firm, established in 2018 with a clear focus on healthcare. The company's slogan, "Investing in two ends of the healthcare spectrum from prevention & behaviour modification to chronic disease management," encapsulates its investment strategy. Relentless is dedicated to investing in disruptive technology, products, and services that optimize access to care and facilitate a robust continuum of care. Its investment sectors encompass a wide range, from preventive health to healthy longevity, including digital health, corporate wellness, and neurotech. As an early stage investor, Relentless targets businesses in their 'start-up' phase and even includes development stage businesses for portfolio balance. The company influences product and market development while leveraging the experience of seasoned advisors and a unique North American network to create additional value. Their most recent investment in a seed round was on 01 January 2020, backed by Helder Ventures. Overall, Relentless Venture Fund stands out for its unwavering commitment to advancing healthcare through technology and innovation, making it a key player in the venture capital landscape.
No recent news or press coverage available for Relentless Venture Fund.